Skip to content
Peptilyze
Tissue repair

LL-37 studies

2,834 journal papers mention LL-37 in the title or abstract. Here are the most cited, the latest, and a few facts about the literature.

Studies range from laboratory work to clinical trials. A paper listed here is not an endorsement and says nothing about whether LL-37 is safe, effective or approved for any use.

Compare LL-37 prices, from €39.99 →

Papers
2,834
2,650 articles, 184 reviews
Earliest paper
1996
Most papers in 2026 (198)
Open access
66%
free to read somewhere
Reviews
6%
of all papers listed

What kind of studies

Of 2,545 papers in PubMed that mention LL-37 in the title or abstract, by the study type PubMed records. Categories overlap, so they do not add up to the total.

  • Randomized controlled trials37
  • Other clinical trials22
  • Meta-analyses and systematic reviews7
  • Other reviews263
  • Case reports11
  • Animal studies only172
  • Studies in humans1,835

Study types are tags assigned by publishers and PubMed indexers; very new papers are often not tagged yet, and a tag is not a quality rating. Retracted papers are excluded. Source: PubMed (NCBI).

Papers per year

1997 to 2026, peak 198 papers in a year. The latest year may still be incomplete.

1997: 2 papers1998: 8 papers1999: 5 papers2000: 12 papers2001: 15 papers2002: 21 papers2003: 29 papers2004: 47 papers2005: 56 papers2006: 75 papers2007: 55 papers2008: 73 papers2009: 88 papers2010: 95 papers2011: 113 papers2012: 115 papers2013: 111 papers2014: 139 papers2015: 133 papers2016: 140 papers2017: 140 papers2018: 144 papers2019: 160 papers2020: 149 papers2021: 143 papers2022: 151 papers2023: 129 papers2024: 129 papers2025: 155 papers2026: 198 papers19972026

Where it is published

  1. Journal of Investigative Dermatology86 papers
  2. PLoS ONE77 papers
  3. International Journal of Molecular Sciences52 papers
  4. Frontiers in Immunology51 papers
  5. The Journal of Immunology49 papers

The papers

Most citedName in the title

  1. Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells

    De Yang, Qian Chen, Albert P. Schmidt et al. · The Journal of Experimental Medicine · 2000

    Study in humansOpen access1,238 citationsRead the open copy →

  2. LL-37, the only human member of the cathelicidin family of antimicrobial peptides

    U. Dürr, U. S. Sudheendra, Ayyalusamy Ramamoorthy · Biochimica et Biophysica Acta (BBA) - Biomembranes · 2006

    ReviewOpen access1,049 citationsRead the open copy →

  3. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18

    Rembert Koczulla, Georges von Degenfeld, Christian Kupatt et al. · Journal of Clinical Investigation · 2003

    Study in humansOpen access864 citationsRead the open copy →

  4. Antibacterial Effect of Human Mesenchymal Stem Cells Is Mediated in Part from Secretion of the Antimicrobial Peptide LL-37

    Anna D. Krasnodembskaya, Yuanlin Song, Xiaohui Fang et al. · Stem Cells · 2010

    Study in humansOpen access853 citationsRead the open copy →

  5. The Expression of the Gene Coding for the Antibacterial Peptide LL-37 Is Induced in Human Keratinocytes during Inflammatory Disorders

    Margareta Frohm, Birgitta Agerberth, Ghasem Ahangari et al. · Journal of Biological Chemistry · 1997

    Study in humansOpen access · CC BY803 citationsRead the open copy →

  6. Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils

    Jeffrey Turner, Yoon Cho, Nhu-Nguyen Dinh et al. · Antimicrobial Agents and Chemotherapy · 1998

    Study in humansOpen access800 citationsRead the open copy →

  7. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface

    Robert Bals, Xiaorong Wang, MICHAEL A. ZASLOFF et al. · Proceedings of the National Academy of Sciences · 1998

    Study in humansOpen access745 citationsRead the open copy →

  8. The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses

    Monisha G. Scott, Donald J. Davidson, Michael R. Gold et al. · The Journal of Immunology · 2002

    Study in humansOpen access713 citationsRead the open copy →

  9. Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation

    Joerg Overhage, Andrea Campisano, Manjeet Bains et al. · Infection and Immunity · 2008

    Study in humansOpen access697 citationsRead the open copy →

  10. Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37

    Jan Johansson, Gudmundur Hrafn Gudmundsson, Martı́n E. Rottenberg et al. · Journal of Biological Chemistry · 1998

    Study in humansOpen access · CC BY662 citationsRead the open copy →

  11. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity

    Ziv Oren, Jeffrey C. Lerman, Gudmundur Hrafn Gudmundsson et al. · Biochemical Journal · 1999

    Study in humansOpen access598 citationsRead the open copy →

  12. The Cathelicidin Anti-Microbial Peptide LL-37 is Involved in Re-Epithelialization of Human Skin Wounds and is Lacking in Chronic Ulcer Epithelium

    Johan D. Heilborn, Margareta Frohm Nilsson, Ole E. Sørensen et al. · Journal of Investigative Dermatology · 2003

    Study in humansOpen access572 citationsRead the open copy →

  13. Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense Peptide LL-37

    Neeloffer Mookherjee, Kelly L. Brown, Dawn M. E. Bowdish et al. · The Journal of Immunology · 2006

    Study in humansOpen access568 citationsRead the open copy →

  14. Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus -Derived Proteinases

    Magdalena Sieprawska‐Lupa, Piotr Mateusz Mydel, Katarzyna Krawczyk et al. · Antimicrobial Agents and Chemotherapy · 2004

    Study in humansOpen access552 citationsRead the open copy →

  15. Structures of Human Host Defense Cathelicidin LL-37 and Its Smallest Antimicrobial Peptide KR-12 in Lipid Micelles

    Guangshun Wang · Journal of Biological Chemistry · 2008

    Study in humansOpen access · CC BY483 citationsRead the open copy →

  16. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL‐37

    Artur Schmidtchen, Inga-Maria Frick, Emma Andersson et al. · Molecular Microbiology · 2002

    Study in humansOpen access440 citationsRead the open copy →

  17. Little Peptide, Big Effects: The Role of LL-37 in Inflammation and Autoimmune Disease

    Joanne Michelle Kahlenberg, Mariana J. Kaplan · The Journal of Immunology · 2013

    ReviewOpen access428 citationsRead the open copy →

  18. The Cationic Antimicrobial Peptide LL-37 Modulates Dendritic Cell Differentiation and Dendritic Cell-Induced T Cell Polarization

    Donald J. Davidson, Andrew J Currie, Gregor S. D. Reid et al. · The Journal of Immunology · 2004

    Study in humansOpen access427 citationsRead the open copy →

  19. Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization

    Di Fan, Laura A. Coughlin, Megan M. Neubauer et al. · Nature Medicine · 2015

    Study in humansOpen access426 citationsRead the open copy →

  20. IFN-γ- and TNF-Independent Vitamin D-Inducible Human Suppression of Mycobacteria: The Role of Cathelicidin LL-37

    Adrian R. Martineau, Katalin Andrea Wilkinson, Sandra M. Newton et al. · The Journal of Immunology · 2007

    Study in humansOpen access410 citationsRead the open copy →

  21. The Antimicrobial Peptide LL-37 Activates Innate Immunity at the Airway Epithelial Surface by Transactivation of the Epidermal Growth Factor Receptor

    Geuranne S. Tjabringa, Jamil Aarbiou, Dennis K. Ninaber et al. · The Journal of Immunology · 2003

    Study in humansOpen access392 citationsRead the open copy →

  22. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways

    Jürgen Schauber · Gut · 2003

    Study in humansOpen access383 citationsRead the open copy →

  23. The human cathelicidin LL-37 — A pore-forming antibacterial peptide and host-cell modulator

    Daniela Xhindoli, Sabrina Pacor, Monica Benincasa et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 2015

    ReviewOpen access366 citationsRead the open copy →

  24. Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37

    Peter G. Barlow, Pavel Svoboda, Annie Mackellar et al. · PLoS ONE · 2011

    Study in humansOpen access · Public domain358 citationsRead the open copy →

  25. In vitro and In vivo Wound Healing-Promoting Activities of Human Cathelicidin LL-37

    Marta Carretero, Maria Jose Escamez, Marta García et al. · Journal of Investigative Dermatology · 2007

    Study in humansOpen access345 citationsRead the open copy →

  26. Cell Differentiation Is a Key Determinant of Cathelicidin LL-37/Human Cationic Antimicrobial Protein 18 Expression by Human Colon Epithelium

    Koji Hase, Lars Eckmann, John D. Leopard et al. · Infection and Immunity · 2002

    Study in humansOpen access · CC BY294 citationsRead the open copy →

  27. The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells

    Seth B. Coffelt, Frank C. Marini, Keri Watson et al. · Proceedings of the National Academy of Sciences · 2009

    Study in humansOpen access292 citationsRead the open copy →

LatestName in title or abstract

  1. Characterization of Immunomodulators and Cellular Signaling Molecules in Cleft Lip and Palate Tissues According to Cleft Laterality

    Laura Ozola, Māra Pilmane, Mārtiņš Vaivads · Journal of Personalized Medicine · 2026

    Open access · CC BYRead the open copy →

  2. Acute Intravenous Tolerability of Antimicrobial Peptides Derived from the Human Cathelicidin LL-37 and Local Antibacterial Activity of Its FK-16 Fragment in A Methicillin-Resistant Staphylococcus epidermidis Rat Femoral Osteotomy Model

    Vincenzo Pennone, Stefania Mamberti, Giada Meogrossi et al. · Antibiotics · 2026

    Open access · CC BYRead the open copy →

  3. Psoríase: Revisão das Bases Imunológicas e Avanços Terapêuticos com Imunobiológicos

    Daniela Costa, Brenda Pessôa, Cendi Freitas et al. · Nursing Edição Brasileira · 2026

    Open access · CC BYRead the open copy →

  4. Regenerative antibiotics: Mesenchymal stromal cells and their secretome as a dual-action platform for antimicrobial therapy and tissue repair

    Sanjay Gottipamula, N. K. Venkataramana · Tzu Chi Medical Journal · 2026

    Open access · CC BY-NC-SARead the open copy →

  5. Rosácea: Patogênese, Classificação por Fenótipos e Tratamento Baseado em Evidências

    Clara Teixeira Junqueira, Lara Sartori Tasca, Leticia Marangoni Alves et al. · Nursing Edição Brasileira · 2026

    Open access · CC BYRead the open copy →

  6. A putative pharmacodynamic ceiling for topical corticosteroids in atopic dermatitis: a steroid-primed inflammasome and caspase-1–mediated glucocorticoid receptor cleavage

    Seung-Yong Seong · Frontiers in Immunology · 2026

    Open access · CC BYRead the open copy →

  7. Understanding antimicrobial peptide activation in mesenchymal stem cells through the aryl hydrocarbon receptor pathway and inflammatory signals

    Cansu Özdemir, BEYZA TURGUT, CEREN TUNCAY et al. · TURKISH JOURNAL OF BIOLOGY · 2026

    Open access · CC BYRead the open copy →

  8. Device-Free Auricular Acupressure for Rosacea

    Bingyang Xu, Jiali Chu, 王晔 et al. · JAMA Dermatology · 2026

    Open accessRead the open copy →

  9. Fever enhances host bacterial defence while limiting mitochondrial damage

    Yonghan Wu, Elijah Rowe, Albert Siryaporn et al. · Nature Communications · 2026

    Open access · CC BYRead the open copy →

  10. The biofilm matrix of uropathogenic Escherichia coli contributes to antimicrobial resistance by reducing molecular transport

    Rutuparna Kulkarni, Zheng Jie Lian, Nguyen Thi Khanh Nhu et al. · npj Biofilms and Microbiomes · 2026

    Open access · CC BY-NC-NDRead the open copy →

  11. LL-37–MRGPRX2–Mast Cell Signaling in Rosacea: Current Evidence and Directions for Human Studies

    Haoyang Yin, 卢益萍 · Clinical Cosmetic and Investigational Dermatology · 2026

    ReviewOpen access · CC BY-NCRead the open copy →

  12. Inflammatory memory as a potential driver of rosacea pathogenesis: integrating mechanisms of chronic relapse and perspectives on disease modification

    Ming Zhang, Zhou Zhou, 詹丹丹 et al. · Frontiers in Immunology · 2026

    ReviewOpen access · CC BYRead the open copy →

  13. The active immune role of keratinocytes: from passive targets to key hubs in psoriatic inflammation

    Yu Pei · Frontiers in Immunology · 2026

    ReviewOpen access · CC BYRead the open copy →

  14. Serum LL-37 levels and their association with disease activity in rheumatoid arthritis, systemic lupus erythematosus and psoriatic arthritis: a cross-sectional study

    Shimaa Elhuseiny Salama, Rasha Adel Elkholy, Doaa Shawky Alashkar et al. · Romanian Journal of Rheumatology · 2026

    Open access · CC BYRead the open copy →

  15. Ameliorative effects and mechanisms of paeonol against rosacea through network pharmacology and experimental validation

    Manyu Chen, Yueye Xu, Xinyu Li et al. · Frontiers in Immunology · 2026

    Study in humansOpen access · CC BYRead the open copy →

  16. Evaluation of a cathelicidin derivative fusion polypeptide for pathogen-targeted antimicrobial approach

    Laura Colomina‐Alfaro, Mihyun Lee, Sixuan Zhang et al. · Applied Microbiology and Biotechnology · 2026

    Open access · CC BYRead the open copy →

  17. Rational design of a dual-function, LL-37/HNP-1, chimeric antimicrobial peptide: a broad-spectrum AMP against respiratory co-infections

    Ghazal Ghaznavi, Navid Nezafat, Cambyz Irajie et al. · Future Journal of Pharmaceutical Sciences · 2026

    Open access · CC BYRead the open copy →

  18. Association of Vitamin D Supplementation with VDR and CAMP Expression and Ulcer Healing in Diabetic Foot Infection Involving Biofilm-Forming Bacteria: An Exploratory Prospective Cohort Study

    Ruby Benson, Saleena Ummer Velladath, Seetharam Prasad et al. · Pharmaceuticals · 2026

    Open access · CC BYRead the open copy →

  19. From joint to artery: association of cathelicidin LL-37 and toll-like receptor 9 with inflammatory markers and atherogenic lipid indices in rheumatoid arthritis

    Muntadher Abdulabbas Hasan Al-Hilo, Zainab Hussein Alhillawi · Egyptian Rheumatology and Rehabilitation · 2026

    Open access · CC BYRead the open copy →

  20. Apoptosis Modulation by LL-37: From Mitochondrial Cell Death to Prosurvival Signaling

    Olga Evgenevna Voronko, Vitalia Sergeevna Novikova, Olesya Olegovna Klychkova et al. · International Journal of Molecular Sciences · 2026

    ReviewOpen access · CC BYRead the open copy →

  21. A soluble recombinant hydroxyapatite-binding LL-37 fusion peptide shows efficient mineral adsorption and repair-associated bioactivity

    Fatemeh Gashtasbi, Sadegh Hasannia, Maryam Nikkhah et al. · Scientific Reports · 2026

    Open access · CC BYRead the open copy →

  22. Full‐length brain‐derived α‐synuclein fibril models reveal fuzzy‐coat control of peptide recognition

    Carlos Pintado‐Grima, Oriol Bárcenas, Giulio Tesei et al. · Protein Science · 2026

    Study in humansOpen accessRead the open copy →

  23. Hypoxia-associated mprF expression and enhanced survival following LL-37 exposure in MRSA biofilms from diabetic foot ulcers

    Abbas Ali Manshd, Hasan Raheem Khudhur, Alaa Ketab Hameed · Microbes and Infectious Diseases /Microbes and Infectious Diseases · 2026

    Open accessRead the open copy →

  24. Mechanism-Guided Antimicrobial Peptide Design through Membrane-Surface Fingerprinting and Graph Diffusion

    Zhenyu Ma, Sixin Tian, Mengmeng Sheng et al. · Journal of Chemical Information and Modeling · 2026

    Open accessRead the open copy →

  25. Anticancer Effect of Dendrosome Nanocurcumin plus LL-37 Antimicrobial Peptide against Colorectal Cancer Cells in vitro and in vivo

    Zahraa Kamil Kadhim Lawi, Saja Mahdey Jaber, Sawsan Mohammed Kareem et al. · Bangladesh Journal of Infectious Diseases · 2026

    Open access · CC BY-NCRead the open copy →

  26. Anti-LL-37 antibodies in synovial fluid reflect disease-specific immunopathogenic mechanisms in psoriatic arthritis

    Stanislava Dimitrova Popova-Belova, Mariela Gencheva Geneva-Popova, Stefka Stoilova et al. · Scientific Reports · 2026

    Open access · CC BY-NC-NDRead the open copy →

  27. Antimicrobial Peptoids Show Potent Antifungal Activity against Candidozyma (Candida) auris In Vivo and Broad-Spectrum Activity In Vitro against Other Candida Species

    Lisa Kathleen Ryan, Isabella M. Griffiths, Uyen ‘Emily’ et al. · ACS Infectious Diseases · 2026

    Study in humansOpen access · CC BYRead the open copy →

  28. Neurogenic Rosacea and Facial Dysesthesia: Neurovascular–Immune Mechanisms and Translational Therapeutic Perspectives

    Serap Maden · Medicina · 2026

    ReviewOpen access · CC BYRead the open copy →

  29. Plasma levels of antimicrobial peptide LL-37 as a biomarker of sleep quality in patients with obstructive sleep apnea: A clinical observational study

    Takayuki Yamaguchi, Keisuke Hosokawa, Takenori Mineta et al. · PLoS ONE · 2026

    Study in humansOpen access · CC BYRead the open copy →

  30. Antifungal and Antibiofilm Effects of LL-37 Against Candida albicans Isolated from Pregnant Women with Vulvovaginal Candidiasis: Impact on FKS1 Gene Expression

    Alaa Aziz Abdulhassan, Hiba Hazim Hamid, Zainab Hekmatt Abood et al. · Natural and Engineering Sciences · 2026

    Open accessRead the open copy →

Each list shows up to 40 papers.See all 2,834 on OpenAlex. Source: OpenAlex (CC0), journal articles and reviews with a DOI, retractions excluded, refreshed weekly, last 4 Nov 2026, 08:26 UTC. Papers are listed by their metadata only; follow the links to read them. A license shown on an open copy is the license the publisher or repository states for that copy.